Cover Image
市場調查報告書

全球疫苗市場分析、主要企業、趨勢 (2016年):兒童用/成人用疫苗 (流感、子宮頸癌、混合、肝炎、肺炎球菌、MMR、水痘、小兒麻庳)

Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)

出版商 Kalorama Information 商品編碼 251887
出版日期 內容資訊 英文 260 Pages
訂單完成後即時交付
價格
Back to Top
全球疫苗市場分析、主要企業、趨勢 (2016年):兒童用/成人用疫苗 (流感、子宮頸癌、混合、肝炎、肺炎球菌、MMR、水痘、小兒麻庳) Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)
出版日期: 2016年03月25日 內容資訊: 英文 260 Pages
簡介

2015年的全球人體疫苗的市場記錄了大幅度的成長。預計2022年,受到新產品的上市和適應症的擴大,尤其是南美、歐洲、印度、中國的利用擴大的影響,成長也進一步加速。

本報告提供全球兒童用疫苗及成人用疫苗的市場相關調查,疫苗開發的過程,免疫反應與作用機制,疫苗的類型,銷售中及開發中的疫苗產品概要,市場收益的變化與預測 (各疫苗類型、地區),主要的市場趨勢,主要製造商的市場佔有率,以及主要企業的簡介等彙整。

第1章 摘要整理

第2章 簡介:疫苗

  • 過程:疫苗的開發
  • 免疫反應
  • 作用機制
  • 疫苗的類型
  • 減毒活病毒疫苗
  • 不活化疫苗
  • 類毒素疫苗
  • 基因重組疫苗
  • 疫苗的認證流程

第3章 兒童用預防疫苗

  • 簡介
  • 幼兒的疫苗接種:美國
  • 幼兒的疫苗接種率
  • 疫苗通知系統的課題
  • 美國的醫療改革的影響
  • 成癮的影響
  • 美國被推薦的幼兒的疫苗接種計劃
  • 州的疫苗接種的推薦
  • 聯合國的倡議
  • 兒童用疫苗產品
  • 成癮
  • BCG
  • 白喉、破傷風、百日咳、B型肝炎、小兒麻庳
  • B型流感(Hib)
  • 手足口病
  • A型肝炎
  • 流感
  • 麻疹、腮腺炎、德國麻疹
  • 腦膜炎感染疾病
  • 副流感
  • 肺炎球菌共軛疫苗
  • 輪狀病毒
  • 呼吸系融合細胞病毒
  • 水痘
  • 開發中的兒童用疫苗
  • 美國的疫苗的成本
  • 全球兒童用預防疫苗市場
  • 整體市場規模、預測
  • 肝炎疫苗市場
  • B型流感疫苗市場
  • 麻疹、腮腺炎、德國麻疹疫苗
  • 混合疫苗
  • 肺炎球菌疫苗
  • 小兒麻庳病毒疫苗
  • 水痘疫苗
  • 其他疫苗市場

第4章 成人用預防疫苗

  • 簡介
  • 可以用疫苗預防的成人發病疾病:資料
  • 「Global Influenza Surveillance Program」
  • 成人的疫苗接種的推薦
  • WHO IHR (International Health Regulations)
  • 成人用疫苗產品
  • BCG
  • 子宮頸癌
  • 霍亂
  • 白喉-破傷風
  • 伊波拉
  • 肝炎
  • 流感
  • 日本腦炎
  • 院內感染疾病
  • 肺炎球菌疾病
  • 狂犬病(恐水症)
  • 帶狀皰疹
  • 傷寒症
  • 黃熱病
  • 開發中的成人用疫苗
  • 全球成人用預防疫苗市場
  • 整體市場規模、預測
  • 子宮頸癌市場
  • 肝炎市場
  • 流感疫苗市場
  • 旅遊用、DT、其他疫苗市場

第5章 疫苗市場:摘要

  • 疫苗市場推動趨勢
  • 市場規模、預測
  • 疫苗的銷售額:各地區
  • 疫苗市場上競爭企業
  • 兒童用疫苗
  • 成人用疫苗

第6章 課題與趨勢

  • 疫苗的安全性
  • 疫苗的不足
  • 全球的流行的防止
  • 疫苗和生物恐怖行動
  • DNA接種
  • 疫苗通知系統的創新
  • 疫苗製造的創新等

第7章 企業簡介

附錄:企業名錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI5948213

‘Vaccines: The World Market’ examines the market for vaccines used in humans to prevent various types of disease. It focuses on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the 2013 to 2017 period and forecasts are provided through 2022.

The global market for human vaccines experienced strong growth through 2015. Through 2022, growth will be fueled by continued new product introductions, indication expansions for some products and rising usage, particularly in South America, Europe, India and China. The report provides a comprehensive market summary, including:

  • Sales Growth of Vaccines vs. Pharmaceuticals, 2013-2022
  • World Market for Vaccines by Type, 2013-2022 (Pediatric, Adult)
  • The World Vaccines Market by Vaccine Type, 2013-2022 (Pediatric: Combinations, Hepatitis, HIB, MMR, Pneumococcal, Poliovirus, Varicella, Others; Adult: Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel - DT - Misc., Total)
  • The World Vaccines Market by Region, 2013-2022 (U.S., North America / Caribbean, South America, EU, Japan, India, China, ROW, Total)
  • Major Manufacturers' Shares of the World Vaccine Market, 2015
  • 2015 World Vaccines Market Share, by Leading Competitors
  • Major Manufacturer's Shares of the World Pediatric Vaccine Market, 2015
  • Major Manufacturers' Shares of the World Adult Vaccine Market, 2015

A wide variety of vaccine products are currently recommended to immunize children against disease. The report examines the developing and current pediatric preventive vaccines market, including:

  • Selected Pediatric Vaccines in Development, March 2016
  • World Market for Pediatric Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others), 2013-2022
  • Market Share of Pediatric Vaccines by Type, 2015 (Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)
  • Market Share of Pediatric Vaccines, by Type, 2022 (Hep, HiB, MMR, Combos, Pneumococcal, Polio, Varicella, Others)
  • World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World), 2013-2022
  • World Pediatric Hepatitis Vaccine Market, 2013-2022
  • World Hib Vaccine Market, 2013-2022
  • World MMR Vaccines Market, 2013-2022
  • World Combination Vaccines Market, 2013-2022
  • World Pediatric Pneumococcal Vaccine Market, 2013-2022
  • World Poliovirus Vaccine Market, 2013-2022
  • World Varicella Vaccine Market, 2013-2022
  • World Pediatric Other Vaccines Market, 2013-2022

Adult immunization is an important, but frequently overlooked, part of patient care. Vaccination programs typically focus on children, yet adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children. The report looks in detail at the adult preventative vaccines market, including:

  • Selected Adult Preventive Vaccines in Development, 2016
  • World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2013-2022
  • Market Share of Adult Vaccines, by Type, 2015 (Cervical Cancer; Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • Market Share of Adult Vaccines, by Type, 2022 (Cervical Cancer; Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World), 2013-2022
  • World Cervical Cancer Vaccine Market, 2013-2022
  • World Hepatitis Vaccine Market, 2013-2022
  • World Influenza Vaccine Market, 2013-2022
  • World Pneumococcal Vaccine Market, 2013-2022
  • World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market, 2013-2022

‘Vaccines: The World Market’ also examines key issues and trends in the global vaccine market today, including product safety and refusal to immunize, obesity, pricing pressure, supply shortages, increasing vaccine development efficiency, and innovations in vaccine delivery systems and production.

The world vaccines market is dominated by several major competitors. The report provides company profiles of these, including:

  • Bavarian Nordic A/S
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • CSL Limited
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hawaii Biotech
  • MedImmune
  • Merck & Co., Inc.
  • Mymetics
  • Opexa Therapeutics
  • Pfizer
  • Sanofi Pasteur

Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • The Global Vaccines Industry
  • Scope and Methodology
  • Overview
  • Pediatric Preventative Vaccines
  • Adult Preventative Vaccines
  • The Market
  • Issues and Trends

TWO: INTRODUCTION TO VACCINES

  • A Brief History: The Development of Vaccines
  • The Immune Response
  • Mechanism of Action
  • Types of Vaccines
  • Attenuated (Weakened) Live Viruses
  • Killed (Inactivated) Viruses
  • Toxoid Vaccines
  • Genetically Engineered/Modified Vaccines
  • Vaccine Approval Process

THREE: PEDIATRIC PREVENTIVE VACCINES

  • Introduction
  • Childhood Immunization in the United States
  • Childhood Immunization Rates
  • Challenges to the Vaccine Delivery System
  • The Effect of U.S. Healthcare Reform
  • The Effect of Addiction
  • Recommended Childhood Immunization Schedule
  • State Immunization Recommendations
  • United Nations Initiatives
  • Pediatric Vaccine Products
  • Addiction
  • BCG
  • Dengue Fever
  • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
  • Haemophilus Influenzae Type B
  • Hand, Foot & Mouth Disease
  • Hepatitis A
  • Influenza
  • Measles, Mumps and Rubella
  • Meningococcal Disease
  • Parainfluenza Virus Type 3
  • Pneumococcal Conjugate
  • Rotavirus
  • Respiratory Syncytial Virus
  • Varicella
  • Pediatric Vaccines in Development
  • Cost of Vaccines in the United States
  • The World Market for Pediatric Preventive Vaccines
  • Total Market Size and Forecast
  • Hepatitis Vaccine Market
  • Haemophilus Influenzae Type B Vaccine Market
  • Measles, Mumps and Rubella Vaccines
  • Combination Vaccines Market
  • Pneumococcal Vaccine
  • Poliovirus Vaccine
  • Varicella Vaccines
  • Other Vaccines Market

FOUR: ADULT PREVENTIVE VACCINES

  • Introduction
  • Adult Vaccine-Preventable Diseases: Facts and Figures
  • Global Influenza Surveillance Program
  • U.S. Surveillance
  • Recommendations for Adult Immunizations
  • WHO International Health Regulations
  • Adult Vaccine Products
  • BCG
  • Cervical Cancer
  • Cholera
  • Diphtheria-Tetanus
  • Ebola
  • Hepatitis
  • Influenza
  • Japanese Encephalitis
  • Nosocomial Infections
  • Pneumococcal Disease
  • Rabies
  • Shingles
  • Typhoid Fever
  • Yellow Fever
  • Adult Vaccines in Development
  • The World Market for Adult Preventive Vaccines
  • Total Market Size and Forecast
  • Cervical Cancer Market
  • Hepatitis Market
  • Influenza Vaccine Market
  • Pneumococcal Vaccine Market
  • Travel, DT, and Miscellaneous Vaccine Market

FIVE: VACCINES MARKET SUMMARY

  • Trends Driving the Vaccines Market
  • Market Size and Forecast
  • Vaccine Sales by Region
  • Vaccine Market Competitors
  • Pediatric Vaccines
  • Adult Vaccines

SIX: ISSUES AND TRENDS

  • Vaccine Safety
  • Refusal to Immunize
  • Obesity
  • Post-Licensure Surveillance
  • The Vaccine Injury Compensation Program
  • World Health Organization
  • Other Initiatives
  • The Future of Vaccine Safety
  • Pricing Pressure
  • Vaccine Shortages
  • Preventing Shortages in the Developed Countries
  • Preventing Shortages in Developing Nations
  • Preventing Pandemics
  • U.S. National Vaccine Plan
  • Vaccines and Bioterrorism
  • Overview
  • Project Bioshield Act
  • National Bio and Agro-Defense Facility
  • Vaccine Treatment and Evaluation Units
  • Anthrax
  • Smallpox
  • Stimulating Vaccine Development
  • Global Health Vaccine Center of Innovation
  • Human Vaccines Project
  • Innovations in Vaccine Delivery Systems
  • Mucosal Delivery
  • Intranasal Delivery
  • Vaccine Patches
  • Vaccine Chips and Microneedles
  • Innovations in Vaccine Production
  • Plants
  • Insects
  • Nanoparticle Systems
  • Cloning

SEVEN: COMPANY PROFILES

  • Bavarian Nordic A/S
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Bharat Biotech
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Crucell /Johnson & Johnson
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • CSL Limited
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Emergent Biosolutions
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial
  • GlaxoSmithKline
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Hawaii Biotech
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • MedImmune
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Merck & Co., Inc
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Mymetics
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Opexa Therapeutics
  • History and Lines of Business
  • Vaccine Products
  • Financial Information
  • Pfizer
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Sanofi Pasteur
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

TWO: INTRODUCTION TO VACCINES

  • Table 2-1: Global Morbidity of Vaccine Preventable Diseases in 1990 vs 2014
  • Figure 2-1: Attenuated Virus Production
  • Table 2-2: Vaccine-Preventable Diseases, March 2016
  • Table 2-3: VAERS Table of Reportable Events Following Vaccination

THREE: PEDIATRIC PREVENTIVE VACCINES

  • Table 3-1: Global Child Immunization Rates for Vaccines Recommended by the WHO, 2015
  • Table 3-2: Immunization Profile of the United States: Population by Age Group,Number of Vaccine-Preventable Diseases Reported by Disease, 1990 - 2014
  • Figure 3-1: National Overdose Death Rates, Number of Deaths from Prescription Drugs, 2001 - 2014
  • Figure 3-2: National Overdose Death Rates, Number of Deaths from Heroin, 2001 - 2014
  • Table 3-3: Marketplace Enrollment as a Share of the Eligible Population, September 2015
  • Table 3-4: U.S. Recommended Immunization Schedule for Children Ages Through 18 Years, 2016
  • Figure 3-3: FluMist Flu Hero
  • Table 3-5: Selected Pediatric Vaccines in Development, March 2016
  • Table 3-6: World Market for Pediatric Vaccines by Type (Hep, HiB, MMR,Combinations, Pneumococcal, Polio, Varicella, Others), 2013-2022 Revenues
  • Figure 3-4: Market Share of Pediatric Vaccines by Type, 2015 (Hep, HiB, MMR,Combos, Pneumococcal, Polio, Varicella, Others)
  • Figure 3-5: Market Share of Pediatric Vaccines, by Type, 2022 (Hep, HiB, MMR,Combos, Pneumococcal, Polio, Varicella, Others)
  • Table 3-7: World Market for Pediatric Vaccines by Region (U.S., North America,South America, EU, Japan, India, China, Rest of World), 2013-2022 Revenues
  • Table 3-8: World Pediatric Hepatitis Vaccine Market, 2013-2022
  • Table 3-9: World Hib Vaccine Market, 2013-2022
  • Table 3-10: World MMR Vaccines Market, 2013-2022
  • Table 3-11: World Combination Vaccines Market, 2013-2022
  • Table 3-12: World Pediatric Pneumococcal Vaccine Market, 2013-2022
  • Table 3-13: World Poliovirus Vaccine Market, 2013-2022
  • Table 3-14: World Varicella Vaccine Market, 2013-2022
  • Table 3-15: World Pediatric Other Vaccines Market, 2013-2022

FOUR: ADULT PREVENTIVE VACCINES

  • Table 4-1: Universal Adult Immunization Schedule, 2016
  • Table 4-2: Summary of Recommendations for Adult Immunization
  • Table 4-3: Initiatives to Require HPV Vaccination by U.S. State, 2016
  • Figure 4-1: U.S. Flu Season Severity from 2002 to 2015
  • Table 4-4: WHO Pandemic Classification Schedule
  • Table 4-5: Selected Adult Preventive Vaccines in Development, 2016
  • Table 4-6: World Market for Adult Preventive Vaccines by Type (Hepatitis,Influenza, Pneumococcal, Travel/DT/Misc.), 2013-2022 Revenues
  • Figure 4-2: Market Share of Adult Vaccines, by Type, 2015 (Cervical Cancer;Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • Figure 4-3: Market Share of Adult Vaccines, by Type, 2022 (Cervical Cancer;Hepatitis; Influenza; Pneumococcal; Travel, DT, Misc.)
  • Table 4-7: World Market for Adult Vaccines by Region (U.S., North America,South America, EU, Japan, India, China, Rest of World), 2013-2022 Revenues
  • Table 4-8: World Cervical CancerVaccine Market, 2013-2022
  • Table 4-9: World Hepatitis Vaccine Market, 2013-2022
  • Table 4-10: World Influenza Vaccine Market, 2013-2022
  • Table 4-11: 2015 Estimated Population by Region and Selected Age Group(Africa,Asia, Europe, North America, Oceania, South America, World)
  • Table 4-12: World Pneumococcal Vaccine Market, 2013-2022
  • Table 4-13: World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market,2013-2022

FIVE: VACCINES MARKET SUMMARY

  • Figure 5-1: Sales Growth of Vaccines vs. Pharmaceuticals, 2013-2022
  • Figure 5-2: World Market for Vaccines by Type, 2013-2022 (Pediatric,Adult)
  • Table 5-1: The World Vaccines Market by Vaccine Type, 2013-2022(Pediatric:
  • Combinations, Hepatitis, HIB, MMR, Pneumococcal, Poliovirus, Varicella, Others;
  • Adult: Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel - DT - Misc.,Total)
  • Figure 5-3: World Market for Vaccines Share by Type, 2013 and 2022 (Pediatric,Adult)
  • Table 5-2: The World Vaccines Market by Region, 2013-2022 (U.S., North America /Caribbean, South America, EU, Japan, India, China, ROW, Total)
  • Table 5-3: Major Manufacturers' Shares of the World Vaccine Market, 2015
  • Figure 5-4: 2015 World Vaccines Market Share, by Leading Competitors
  • Table 5-4: Major Manufacturer's Shares of the World Pediatric Vaccine Market,2015
  • Figure 5-5: Market Share of Pediatric Vaccines Market, 2015
  • Table 5-5: Major Manufacturers' Shares of the World Adult Vaccine Market,2015
  • Figure 5-6: Market Share of Adult Vaccines Market, 2015

SIX: ISSUES AND TRENDS

  • Figure 6-1: Refusal to Vacinate Form
  • Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines

SEVEN: COMPANY PROFILES

  • Figure 7-1: Bharat Biotech's Product Pipeline, March 2016
  • Figure 7-2: Sanofi Pasteur's Product Pipeline, March 2016
Back to Top